Mitotype Precision Labs

Mitotype Precision Labs is a contract research organisation providing patient-derived cellular assays for drug discovery and preclinical evaluation.

Its screening services use fibroblasts, neurons and astrocytes to measure mitochondrial function, lysosomal biology and other disease-relevant cellular responses. The company supports compound screening, lead optimisation, toxicity assessment and biomarker research.

Its models are particularly relevant to neurodegenerative and rare diseases, helping pharmaceutical and biotechnology researchers prioritise compounds using human cellular evidence.